Eli Lilly Australia | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,885 results for “Eli Lilly Australia”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

20 participants · First posted Sep 22, 2023

Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

85 participants · First posted Sep 7, 2012

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

263 participants · First posted Apr 25, 2018

Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands)

30 participants · First posted Aug 16, 2021

CTRI/2014/06/004668

A Bioequivalence study comparing Gemcitabine injection (Manufactured by: Intas Pharmaceuticals Ltd.) to the reference listed drug Gemzar injection (Eli Lilly and Company) in patients with Pancreatic or Ovarian Cancer

44 participants

SNIFF Multi-Device Study 2

30 participants · First posted Dec 16, 2019

A Study in People With Abnormal Fat Levels in the Blood

300 participants · First posted Jun 30, 2005

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

15 participants · First posted Apr 15, 2015

MagDI Australia Study

25 participants · First posted Jun 25, 2024

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

25 participants · First posted Apr 21, 2021

Page 1 of 104